Clinical trial · Observational
Multi-center Study on Therapy-oriented Molecular Subtyping of Hepatocellular Carcinoma
NCT03668158CI-TRIAL-00035430unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to establish molecular subtyping of HCC.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hepatocellular Carcinoma | Hepatocellular Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- recurrent HCC
- description
- recurrent HCC after LT
- label
- non-recurrent HCC
- description
- non- recurrent HCC after LT
Primary outcomes (1)
- measure
- recurrence rate
- timeFrame
- 2 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: Liver transplantation due to HCC within Hangzhou criteria Exclusion Criteria: Liver transplantation due to HCC beyond Hangzhou criteria Liver transplantation due to other disease except HCC Multiple organ transplantation
References
Publications (0)
Data not yet available
No reference posted for this study.